KIFFIK Biomedical, Inc.

About KIFFIK Biomedical, Inc.

KIFFIK EXP is a biomedical company focused on unlocking the diagnostic power of interstitial fluid (ISF) through a real-time biomarker monitoring platform. Their mission is to provide earlier, more accurate insights for pharmaceutical, diagnostic, and research applications by continuously collecting molecular signals that blood misses.

Products & Services

KIFFIK EXP™ Platform:A proprietary, non-invasive wearable device for real-time biomarker monitoring from interstitial fluid (ISF), offering continuous data for clinical trials, diagnostics, and research across multiple therapeutic areas like oncology, autoimmune, and neurodegenerative diseases. Not FDA cleared, for investigational use only.

KIFFIK Lab:A platform supporting scalable, repeatable access to ISF for biomarker discovery and translational research, enabling real-time molecular data collection without blood draws. Not FDA cleared, for investigational use only.

Specialties

Real-time biomarker monitoring Interstitial fluid (ISF) diagnostics Non-invasive wearable devices Clinical trial support Companion diagnostics development Translational biomarker discovery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Share Subscription Facility T: - FT: Share Subscription Facility	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2023-10-10 FD: 2023-10-10	1 investors

Share Subscription Facility Latest

2023-10-10

$50.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Dr. Abdeltif Essalik

Inventor

G

George Cagna

Chief Executive Officer

B

Brian T. Dougan

Chief Legal Officer

R

Rene Veloso

Chief Investment Officer

H

Hap Peterson

Chief Operating Officer

R

Reginald Swift

Chief Scientific Officer

View 20 more team members with Pro

Unlock Full Team Directory

Recent News